Post di Cannon Artes

La diciottesima sessione del 63° Simposio AFI, dal titolo “𝑰𝒍 𝒓𝒖𝒐𝒍𝒐 𝒅𝒆𝒈𝒍𝒊 𝑨𝑷𝑰 𝒏𝒆𝒈𝒍𝒊 𝒔𝒗𝒊𝒍𝒖𝒑𝒑𝒊 𝒅𝒆𝒍𝒍𝒂 𝒓𝒆𝒈𝒐𝒍𝒂𝒎𝒆𝒏𝒕𝒂𝒛𝒊𝒐𝒏𝒆 𝒆𝒖𝒓𝒐𝒑𝒆𝒂”, è dedicata ai 𝐩𝐫𝐢𝐧𝐜𝐢𝐩𝐢 𝐚𝐭𝐭𝐢𝐯𝐢 𝐟𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐢 e si concentra sugli sviluppi normativi attesi a livello europeo e sul loro impatto nelle attività dei produttori di #API. Alla luce delle evoluzioni normative in atto e in considerazione della crescente importanza del fattore #sostenibilità, infatti, la sessione porrà l'attenzione sugli elementi chiave che impattano sulla 𝐠𝐞𝐬𝐭𝐢𝐨𝐧𝐞 𝐝𝐞𝐠𝐥𝐢 𝐚𝐬𝐩𝐞𝐭𝐭𝐢 𝐧𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐢, presenterà i più recenti 𝐚𝐩𝐩𝐫𝐨𝐜𝐜𝐢 𝐭𝐞𝐜𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐢 𝐩𝐞𝐫 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢 𝐩𝐫𝐨𝐝𝐮𝐭𝐭𝐢𝐯𝐢 𝐚 𝐦𝐢𝐧𝐨𝐫 𝐢𝐦𝐩𝐚𝐭𝐭𝐨 e proporrà un aggiornamento sulla 𝐬𝐢𝐭𝐮𝐚𝐳𝐢𝐨𝐧𝐞 𝐝𝐞𝐠𝐥𝐢 𝐀𝐏𝐈 𝐜𝐫𝐢𝐭𝐢𝐜𝐢 𝐬𝐨𝐭𝐭𝐨 𝐚𝐭𝐭𝐞𝐧𝐳𝐢𝐨𝐧𝐞 𝐚 𝐜𝐚𝐮𝐬𝐚 𝐝𝐞𝐥 𝐫𝐢𝐬𝐜𝐡𝐢𝐨 𝐝𝐢 𝐜𝐚𝐫𝐞𝐧𝐳𝐞. Nella nostra videointervista, Piero Iamartino, Presidente dell'EIPG, illustra brevemente questi tre temi, sui quali si focalizzeranno gli interventi previsti durante la sessione del 7 giugno. 👉 Qui l'intervista completa: https://lnkd.in/dtpfaJg2 AFI - ASSOCIAZIONE FARMACEUTICI INDUSTRIA #simposioafi2024

🚀  Biosimilars LatAm - Brazil 2024 will feature a high-level panel to discuss strategies for improving biosimilars access in Brazil. Our speakers include Francisco Javier D., Andre Luiz Jochen, and Paulo Fernandes who will share their expertise and experiences to find innovative solutions. They will also provide in-depth analysis and future strategies to enhance biosimilars access 🌟 🗓️ Date: August 21-22, 2024  📍 Venue: Pullman Ibirapuera #SãoPaulo Hotel There are only 8 days left until this crucial forum begins. Don’t miss out—Register Now! 🚨  https://lnkd.in/d5RTHdk2 If you are affiliated with any of the following organizations, please contact us for a discount code: 🤝 ABIFINA, ABIQUIFI, ABRACRO, Alianza de CROs de Mexico (ACROM), ALANAC - Associação dos Laboratórios Farmacêuticos Nacionais, AMELAF, Amepres México, CANIFARMA, CAPGEN - Cámara Argentina de Productores de Medicamentos Hospitalarios, IGBA - International Generic and Biosimilar medicines Association, PróGenéricos, SINDIFARGO, União Farmacêutica de São Paulo - UNIFAR #BiosimilarsForum #Brazil2024 #Healthcare #AccessToMedicines

Argomento sempre interessante, posti limitati !

Want to learn more about hot topics for pharmaceuticals regarding market access & public procurement? Join us at our upcoming PharmaAccess event in Paris! Register here: https://lnkd.in/ebcy8pSF hashtag #marketaccess hashtag #pharmaceuticals hashtag #publicprocurement

📖 È giovedì e come da tradizione torna la #newsletter di NCF - Notiziario Chimico Farmaceutico. Vediamo insieme le notizie selezionate dalla Redazione questa settimana. 💊 Il position paper di EFPIA - European Federation of Pharmaceutical Industries and Associations sul drug repurposing 🦠 I risultati dell’analisi integrata EMA/ECDC/EFSA sul consumo di antimicrobici 🩹 Le prospettive per i dispositivi di automedicazione in un report IQVIA/AESGP 🥳 𝗖𝗲𝗹𝗲𝗯𝗿𝗶𝗮𝗺𝗼 𝗶𝗻𝘀𝗶𝗲𝗺𝗲 𝗶 𝟲.𝟬𝟬𝟬 𝗳𝗼𝗹𝗹𝗼𝘄𝗲𝗿 𝘀𝘂 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻! 📌 Iscrivetevi alla nostra #newsletter per rimanere sempre aggiornati: https://lnkd.in/dA-fBWYA

Yesterday, we were honoured to be a part of the EU #CriticalMedicinesAlliance launch, represented by 15 of our member CEOs.  We thank them for their commitment and dedication to ensuring a secure supply of medicines in Europe. Over 90% of the EU critical medicines list are essential, #GenericMedicines. They need dedicated policy actions to secure their supply, including: 💊A concrete shortage prevention-strategy 🤝Partnership between the EU and our industry 🔓A shared commitment to ensure access, availability and supply security based on EU solidarity. Read our vision for the EU Critical Medicines Alliance at https://lnkd.in/dG949KJN See our proposal for a critical medicine act at  https://lnkd.in/dgt65ahU Elisabeth Stampa, Medichem, S.A. - Rebecca Guntern, Sandoz - Markus Sieger, Polpharma - Steffen Saltofte, Zentiva - Philippe Drechsle, Teva Pharmaceuticals - Martha Christopoulou, Baxter International Inc. - Stephan Eder, STADA Group - Artur Cwiok, Viatris - Csaba Poroszlai, Egis Pharmaceuticals PLC - Bruno Belli, Fresenius Kabi - Lucas Sigman, Insud Pharma - THEODOROS TRYFON, Elpen Pharmaceutical Co. Inc., Πανελλήνια Ένωση Φαρμακοβιομηχανίας (ΠΕΦ) - PEF - Andreas Loizou, Medochemie Ltd Adrian van den Hoven - Giuliana Pennisi European Commission Belgian Presidency of the Council of the European Union 2024 #AccessForAll #LevellingUp

"Advancing the frontier. Enhancing nitrosamines analysis with a deep dive into nitroso drug substance-related impurities (ndsris)" è il titolo del webinar che emergee sagl organizza per il 19 aprile, in collaborazione con AFTI - Associazione Farmaceutici Ticinese e Mérieux NutriSciences - Italia Un'occasione da non perdere per tutti coloro che lavorano nel settore farmaceutico, nel quale essere all'avanguardia nelle sfide analitiche è fondamentale per garantire sicurezza e conformità. Questo webinar esclusivo accende i riflettori su uno dei problemi più pressanti dell'analisi farmaceutica odierna: le nitrosammine. Le impurezze da nitrosammina, in particolare le impurezze correlate a sostanze farmaceutiche nitroso (NDSRI), pongono sfide significative all'industria farmaceutica, rendendo la loro analisi accurata più critica che mai e la loro comparsa ha suscitato un'attenzione normativa globale. Il webinar, presentato da Marco Vigano' - Lab Solutions Sales Manager di emergee e condotto da Sergio Fasan - Business Director della Business Unit Pharma e da Emiliano De Dominicis - Chemistry Research Director, promette un'esplorazione approfondita dell'analisi delle nitrosamine. Verranno in particolare toccati questi argomenti: 🔎 Emersione e impatto. Comprensione dell'importanza delle NDSRI e delle loro implicazioni per la sicurezza dei farmaci. 🔎 Sfide analitiche. Affrontare gli ostacoli nello sviluppo di metodi robusti per il rilevamento delle nitrosammine. 🔎 Controllo di qualità. Strategie per l'implementazione di rigorosi test di controllo della qualità per garantire la conformità e la sicurezza. 🔎 Casi di studio. Approfondimenti reali dai laboratori di nitrosammine di Mérieux NutriSciences, che offrono uno sguardo agli aspetti pratici dell'analisi delle nitrosammine. Il webinar, totalmente gratuito, sarà in inglese e si svolgerà online dalle 9.00 alle 12.00 venerdì 19 aprile. Per questioni organizzative le iscrizioni si raccolgono entro e non oltre il 17 aprile sul sito di AFTI.

I was thrilled to be part of such crucial first step towards a Critical Medicines Act. Indeed, we need to complement the #PharmaLegislation with a strong toolkit to tackle #medicineShortages that are adversely affecting patients across Europe. Under the auspices of the European Commission President Ursula von der Leyen the Belgian Presidency of the Council of the European Union 2024 led by Frank Vandenbroucke, Deputy Prime Minister and Minister of Social Affairs and Public Health, along with Commissioner for Health Stella Kyriakides and EU 27 Ministers of Health, the EU #CriticalMedicinesAlliance was officially launched. 15 CEOs representing Medicines for Europe presented our comprehensive approach to secure medicine supplies: 💊 A concrete shortage prevention strategy that includes EU medicines procurement guidelines rewarding security of medicine supply as well as the use of existing IT systems to predict and prevent shortages (such as the serialization system). 🤝 Collaboration between the EU and industry to enhance EU manufacturing competitiveness through digital and environmental innovations in production technologies. This can be facilitated through State Aids and IPCEI initiatives for off-patent medicines. 🔓 Concrete EU 27 solidarity should be our health mantra to deliver equity of access across EU Member States. We must avoid national stockpiling mandates, as they could result in oversupply in larger countries and shortage risks in smaller ones. According to the IQVIA MIDAS database, the German 6-months stockpile is equal to 10 Member Staes annual consumption and stockpile combined (see infographic below). We are ready to further collaborate with EU Institution, Member States and health stakeholders. Action is needed now! 💪🏼 #MedsSecurity #AccessEquity #LevelUP #EUhealthUnion #EUsolidarity #EU2024BE

Many thanks to the BEAM Alliance for inviting us to join their webinar series! In today’s session, the Swiss Round Table on Antibiotics made the case for why we need both pull and push incentives to bring new antimicrobial technologies to patients. The speakers, Rudolf Blankart, Chantal Morel, and Barbara Polek, discussed topics such as: - The antibiotic challenge: Why is the #antibiotics market far less attractive than the markets for other #pharmaceuticals? -  "Business as usual" is not an option: If we don’t find a solution to solve the major #publichealth challenge posed by #antimicrobialresistance, the costs of non-action will conceivably be enormous. - Implementation of pull incentives is gaining momentum: England and Sweden have been conducting pilot projects to test revenue guarantee models; other countries are planning to do so. In our White Paper "Effective antibiotics for the Swiss health care system: today and in the future" we suggest how a pilot project could be implemented in Switzerland to test a pull incentive-model. You will find the publication on our website: https://lnkd.in/eYVvPy_T #AMR, #globalhealth, #silentpandemic

 🔹#farmaci biologici-biosimilari: linee guida ed indicatori per l’appropriatezza prescrittiva della Regione Calabria! 🔹 👉🏼Consulta l’𝙖𝙥𝙥𝙧𝙤𝙛𝙤𝙣𝙙𝙞𝙢𝙚𝙣𝙩𝙤 sul #pharmakit ➡️ https://www.pharmakit.it/ Dott.ssa Agnese Solari   #farmacibiologici #biosimilari #pharma #appropriatezzaprescrittiva #farmaceutica #farmaco